Giraffe Bio is a developer of biomolecular technology to improve efficiency and sustainability in critical mineral extraction. The
Giraffe Bio has raised $6.4M in total funding. The most recent round was Seed. The last funding was announced in October 2026.
Giraffe Bio's investors include SOSV, BHP, SOSV SF & NY (Fka IndieBio), Baruch Future Ventures, Orion Industrial Ventures.
Giraffe Bio is headquartered in Buenos Aires, Argentina.
Giraffe Bio is a developer of biomolecular technology to improve efficiency and sustainability in critical mineral extraction. The
Giraffe Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Giraffe Bio — Funding & Investors." VCBacked, October 13, 2026, https://www.vcbacked.co/company/giraffe-bio. Accessed November 14, 2026.
VCBacked. (2026). Giraffe Bio — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/giraffe-bio
{{cite web |title=Giraffe Bio — Funding & Investors |url=https://www.vcbacked.co/company/giraffe-bio |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Giraffe Bio? Request a listing update